Arcutis Biotherapeutics Cash from Investing (TTM) Trends

Arcutis Biotherapeutics Inc (ARQT)

8.355 -0.40 (-4.51%) USD | NASDAQ | Apr 25, 12:15

Cash from Investing (TTM) Chart

Historical Cash from Investing (TTM) Data

View and export this data back to 2019. Upgrade now.

Date	Value
December 31, 2023	180.23M
September 30, 2023	284.62M
June 30, 2023	41.81M
March 31, 2023	5.255M
December 31, 2022	-87.20M
September 30, 2022	-105.90M
June 30, 2022	94.83M
March 31, 2022	-122.65M
December 31, 2021	-75.95M

Date	Value
September 30, 2021	-175.34M
June 30, 2021	-270.53M
March 31, 2021	-99.50M
December 31, 2020	-181.82M
September 30, 2020	-141.93M
June 30, 2020	-29.12M
March 31, 2020	-37.38M
December 31, 2019	-26.32M

Cash From Investing Definition

Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.

Read full definition.

Cash from Investing (TTM) Range, Past 5 Years

-270.53M

Minimum

Jun 2021

284.62M

Maximum

Sep 2023

-43.94M

Average

-75.95M

Median

Dec 2021

Cash from Investing (TTM) Benchmarks